-
1
-
-
0033304934
-
The insulin-related ovarian regulatory system in health and disease
-
Poretsky L., Cataldo N.A., Rosenwaks Z., and Giudice L.C. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20 (1999) 535-582
-
(1999)
Endocr Rev
, vol.20
, pp. 535-582
-
-
Poretsky, L.1
Cataldo, N.A.2
Rosenwaks, Z.3
Giudice, L.C.4
-
2
-
-
0036309841
-
Obesity and the polycystic ovary syndrome
-
Gambineri A., Pelusi C., Vicennati V., Pagotto U., and Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metabol Dis 26 (2002) 883-896
-
(2002)
Int J Obes Relat Metabol Dis
, vol.26
, pp. 883-896
-
-
Gambineri, A.1
Pelusi, C.2
Vicennati, V.3
Pagotto, U.4
Pasquali, R.5
-
3
-
-
0142185995
-
Insulin lowering agents in the management of the polycystic ovary syndrome
-
De Leo V., La Marca A., and Petraglia F. Insulin lowering agents in the management of the polycystic ovary syndrome. Endocr Rev 24 (2003) 633-667
-
(2003)
Endocr Rev
, vol.24
, pp. 633-667
-
-
De Leo, V.1
La Marca, A.2
Petraglia, F.3
-
4
-
-
0041736553
-
Metformin. new understanding, new uses
-
Hundal R.S., and Inzucchi S.E. Metformin. new understanding, new uses. Drugs 63 (2003) 1879-1894
-
(2003)
Drugs
, vol.63
, pp. 1879-1894
-
-
Hundal, R.S.1
Inzucchi, S.E.2
-
5
-
-
0142247208
-
Metformin in polycystic ovary syndrome. systematic review and meta-analysis
-
Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome. systematic review and meta-analysis. BMJ 327 (2003) 951-957
-
(2003)
BMJ
, vol.327
, pp. 951-957
-
-
Lord, J.M.1
Flight, I.H.2
Norman, R.J.3
-
6
-
-
8344289055
-
Insulin-sensitizing agents as primary therapy for patients with polycystic ovary syndrome
-
Kashyap S., Wells G.A., and Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic ovary syndrome. Hum Reprod 19 (2004) 2474-2483
-
(2004)
Hum Reprod
, vol.19
, pp. 2474-2483
-
-
Kashyap, S.1
Wells, G.A.2
Rosenwaks, Z.3
-
7
-
-
0029016829
-
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator activated receptor gamma (PPAR gamma)
-
Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator activated receptor gamma (PPAR gamma). J Biol Chem 270 (1995) 12953-12956
-
(1995)
J Biol Chem
, vol.270
, pp. 12953-12956
-
-
Lehmann, J.M.1
Moore, L.B.2
Smith-Oliver, T.A.3
Wilkison, W.O.4
Willson, T.M.5
Kliewer, S.A.6
-
8
-
-
19244365650
-
Thiazolidinediones
-
Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351 (2004) 1106-1118
-
(2004)
N Engl J Med
, vol.351
, pp. 1106-1118
-
-
Yki-Jarvinen, H.1
-
9
-
-
0035041906
-
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome. a multicenter, double blind, placebo-controlled trial
-
PCOS/Troglitazone Study Group
-
Azziz R., Ehrmann D., Legro R.S., Whitcomb R.W., Hanley R., Fereshetian A.G., and PCOS/Troglitazone Study Group. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome. a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86 (2001) 1626-1632
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1626-1632
-
-
Azziz, R.1
Ehrmann, D.2
Legro, R.S.3
Whitcomb, R.W.4
Hanley, R.5
Fereshetian, A.G.6
-
10
-
-
1642297316
-
Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome
-
Belli S.H., Graffigna M.N., Oneto A., Otero P., Schurman L., and Levalle O.A. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertil Steril 81 (2004) 624-629
-
(2004)
Fertil Steril
, vol.81
, pp. 624-629
-
-
Belli, S.H.1
Graffigna, M.N.2
Oneto, A.3
Otero, P.4
Schurman, L.5
Levalle, O.A.6
-
11
-
-
4043100289
-
Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome
-
Brettenthaler N., De Geyter C., Huber P.R., and Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 3835-3840
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 3835-3840
-
-
Brettenthaler, N.1
De Geyter, C.2
Huber, P.R.3
Keller, U.4
|